Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes-Reference-Cited by-同舟云学术

Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes

Published:2020-02 Issue:1 Volume:2 Page:100065
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Ginn Samantha L.,Amaya Anais K.^ORCID,Liao Sophia H.Y.,Zhu Erhua^ORCID,Cunningham Sharon C.,Lee Michael^ORCID,Hallwirth Claus V.^ORCID,Logan Grant J.^ORCID,Tay Szun S.,Cesare Anthony J.^ORCID,Pickett Hilda A.,Grompe Markus,Dilworth Kimberley^ORCID,Lisowski Leszek^ORCID,Alexander Ian E.^ORCID

Funder

National Health and Medical Research Council

University of Sydney

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference47 articles.

1. Long-term safety and efficacy of factor IX gene therapy in hemophilia B;Nathwani;N Engl J Med,2014

2. Gene therapy for metabolic disorders: an overview with a focus on urea cycle disorders;Alexander;J Inherit Metab Dis,2012

3. Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I;Berraondo;J Hepatol,2015

4. MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease;Satishchandran;Gastroenterology,2018

5. Adeno-associated virus (AAV) vectors in cancer gene therapy;Santiago-Ortiz;J Control Release,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAV-delivered hepato-adrenal cooperativity in steroidogenesis: Implications for gene therapy for congenital adrenal hyperplasia;Molecular Therapy - Methods & Clinical Development;2024-06

2. A bioinformatic analysis of gene editing off-target loci altered by common polymorphisms, using ‘PopOff’;Journal of the Royal Society of New Zealand;2024-05-09

3. Donor template delivery by recombinant adeno-associated virus for the production of knock-in mice;BMC Biology;2024-02-02

4. Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies;Human Gene Therapy;2023-09-01

5. Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency;Children;2023-08-09